Zantac and NDMA Contamination

Zantac (ranitidine) was recalled worldwide after it was discovered that the popular heartburn medication contained NDMA, a probable human carcinogen. Millions of people who took Zantac may have been exposed to dangerous levels of this cancer-causing substance.

Pharmaceutical consultation

Understanding Zantac Cancer Risks

NDMA Contamination

Zantac contained N-Nitrosodimethylamine (NDMA), a probable human carcinogen that can cause cancer.

Widespread Use

Zantac was one of the most popular over-the-counter and prescription heartburn medications for decades.

Global Recall

The FDA and health authorities worldwide recalled Zantac products due to NDMA contamination concerns.

Do You Qualify for a Zantac Lawsuit?

Zantac Use

You regularly took Zantac (ranitidine) for heartburn, acid reflux, or other stomach conditions.

Cancer Diagnosis

You were diagnosed with stomach, bladder, liver, kidney, or other cancers linked to NDMA exposure.

Duration of Use

You used Zantac for an extended period, increasing your exposure to NDMA contamination.

Timeline

Your cancer diagnosis occurred after taking Zantac products containing NDMA.

Did You Develop Cancer After Taking Zantac?

You may be entitled to compensation for medical expenses, pain and suffering, and lost wages. Get your free case review today.